Skip to main content
MHRP

Main navigation

  • About Us
    • Our Team
      • Leadership
      • Researchers
      • Global Health
      • Labs
    • WRAIR
    • HJF
    • Impact
    • Fact Sheets
    • Newsletters
    • Contact Us
  • PEPFAR
    • Kenya
    • Nigeria
    • Tanzania
    • Uganda
  • HIV Research
    • Vaccine Research
      • Vaccine Approaches
      • MFV Vaccine Design
      • ALF Adjuvants
      • RV144 Thai Trial
    • Monoclonal Antibodies (mAbs)
      • Bispecific Antobodies
    • Acute HIV and Cure Research
      • RV217
      • RV254
      • HIV Cure
      • Martin Delaney Collaboratories
    • Epidemiology and Threat Assessment
      • Cohorts and Other Observational Studies
      • Clinical Trials
  • Global Research
    • Georgia
    • Germany
    • Jordan
    • Kenya
    • Mozambique
    • Nigeria
    • Tanzania
    • Thailand
    • Uganda
  • News
  • Careers
    • Benefits & Culture
    • Current Opportunities
    • International Careers
    • Meet the Team
  • Search
Hero

Infection, Prevention and Control (IPC) Evaluation in Nigeria


"Protecting healthcare workers and patients during the COVID-19 pandemic: a comparison of baseline and follow-up infection prevention and control needs in Nigerian military healthcare facilities delivering HIV services" 

Sign Up For Our Newsletter

WRAIR WRAIR MHRP
HJF HJF

Social Navigation

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Footer

  • Accessibility
  • Disclaimers
  • Privacy
  • Contact MHRP

©2022 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

This site was created by HJF. The appearance of U.S. Department of Defense visual information does not imply or constitute DoD endorsement.